Literature DB >> 9008450

Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response.

H Mudra1, E Regar, V Klauss, F Werner, K H Henneke, E Sbarouni, K Theisen.   

Abstract

BACKGROUND: The effects of ultrasound-guided high-pressure stenting on late stent and reference segment dimensions are unknown. In this study, we report about angiographic and ultrasound measurements to assess the amount and distribution of neointimal ingrowth within the stent and the changes of plaque burden and dimensions within the reference segments. METHODS AND
RESULTS: Sixty-eight consecutive patients with 72 lesions received single or multiple Palmaz-Schatz coronary stents with a standardized protocol for stent optimization under ultrasound guidance. The residual angiographic diameter stenosis was 3 +/- 12% (reference diameter, 3.16 +/- 0.61 mm). At follow-up 4.8 +/- 2.5 months later, angiography revealed a diameter stenosis of 27 +/- 21% with a restenosis rate of 15.3% (confidence interval: 7.8% to 25.6%). Lumen renarrowing within the stent was exclusively due to neointimal ingrowth; no stent compression was observed. The neointima covered 20 +/- 20% of the stent area and was more pronounced in the midportion of the stent. Volumetric assessment performed in 26 patients resulted in 13 +/- 14% or 65 +/- 28% of the stent volume occupied by neointimal ingrowth in patients without or with restenosis, respectively. Vessel remodeling had an impact on lumen dimensions only at reference sites but not within the stent. Plaque burden of 46 +/- 11% and 48 +/- 11% at the proximal and distal reference sites, respectively, did not show a relevant progression during the follow-up.
CONCLUSIONS: Serial ultrasound analyses did not show any evidence of stent compression or relevant vessel remodeling. Restenosis was solely due to neointimal ingrowth. Despite a considerable plaque burden within the reference segments, there was no relevant progression of the disease adjacent to the stent.

Entities:  

Mesh:

Year:  1997        PMID: 9008450     DOI: 10.1161/01.cir.95.2.363

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy.

Authors:  Patrick C H Hsieh; Richard D Kenagy; Eileen R Mulvihill; Joseph P Jeanette; Xi Wang; Cindy M C Chang; Zizhen Yao; Walter L Ruzzo; Suzanne Justice; Kelly L Hudkins; Charles E Alpers; Scott Berceli; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

2.  Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound.

Authors:  C von Birgelen; G S Mintz; E A de Vrey; P W Serruys; T Kimura; M Nobuyoshi; J J Popma; M B Leon; R Erbel; P J de Feyter
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 3.  [Pathophysiology and therapeutic concepts in coronary restenosis].

Authors:  H G Klues; P W Radke; R Hoffmann; J vom Dahl
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

4.  Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: a serial intravascular ultrasound analysis.

Authors:  Young Joon Hong; Myung Ho Jeong; Yun Ha Choi; Eun Hye Ma; Jum Suk Ko; Min Goo Lee; Keun Ho Park; Doo Sun Sim; Nam Sik Yoon; Hyun Ju Youn; Kye Hun Kim; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 3.165

Review 5.  Intracoronary ultrasound.

Authors:  C Hammond; J P Causer; R A Perry
Journal:  Postgrad Med J       Date:  1998-08       Impact factor: 2.401

6.  The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era.

Authors:  Chengbin Zheng; Jeehoon Kang; Kyung Woo Park; Jung-Kyu Han; Han-Mo Yang; Hyun-Jae Kang; Bon-Kwon Koo; Hyo-Soo Kim
Journal:  J Interv Cardiol       Date:  2019-07-01       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.